GlassScriptPhysician profile
Sumeet Soni
NPI 1962885293
$2,494.33
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $485 · 2023: $1,451 · 2024: $558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,909 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,909.46 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $612.27 | 2022-2024 | Breztri, Tezspire, Fasenra |
| Glaxosmithkline, LLC. | $383.47 | 2022-2024 | Trelegy Ellipta, Nucala, Arexvy |
| Genzyme Corporation | $278.54 | 2022-2023 | |
| Mallinckrodt Hospital Products INC. | $230.46 | 2023-2024 | Acthar |
| Regeneron Healthcare Solutions, INC. | $214.30 | 2023-2024 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $167.14 | 2022-2024 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Amgen INC. | $123.33 | 2022-2023 | Tezspire, Tavneos |
| Insmed, INC. | $112.16 | 2022-2024 | Arikayce |
| Mylan Specialty L.P. | $78.89 | 2022-2023 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $73.56 | 2023 | Glassia |
| Philips North America LLC | $70.29 | 2022-2023 | |
| Abbvie INC. | $33.72 | 2023 | Avycaz, Dalvance |
| Grifols USA, LLC | $27.16 | 2024 | Prolastin-C Liquid |
| Baxter Healthcare | $26.54 | 2023 | Hillrom - Life 2000 Ventilation System |
| Beckman Coulter, INC. | $24.97 | 2024 | Dxh 900 Hematology System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $21.69 | 2024 | Zerbaxa, Dificid, Recarbrio |
| Novartis Pharmaceuticals Corporation | $15.84 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumeet Soni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.